BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3989336)

  • 1. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
    Merritt JA; Borden EC; Ball LA
    J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment.
    Merritt JA; Meltzer DM; Ball LA; Borden EC
    Prog Clin Biol Res; 1985; 202():423-30. PubMed ID: 3832076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
    J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
    Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
    J Interferon Res; 1986 Jun; 6(3):189-98. PubMed ID: 3745984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
    Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
    Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells by gamma interferon.
    Triozzi PL; Sedwick WD; Iland HJ; Richards RG; Laszlo J
    J Biol Response Mod; 1986 Dec; 5(6):562-70. PubMed ID: 3098928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of interferon levels, antiviral state, 2',5'-oligoadenylate synthetase and side effects in healthy men.
    Barouki FM; Witter FR; Griffin DE; Nadler PI; Woods A; Wood DL; Lietman PS
    J Interferon Res; 1987 Feb; 7(1):29-39. PubMed ID: 3035034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
    Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
    J Interferon Res; 1992 May; Spec No():7-16. PubMed ID: 1640114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
    Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2',5' oligoadenylate synthetase activity in bovine peripheral blood mononuclear cells following bovine herpesvirus type-1-induced respiratory disease: a prognostic indicator?
    Bielefeldt Ohmann H; Campos M; Harland R; Griebel PJ; Babiuk LA
    J Interferon Res; 1989 Apr; 9(2):159-66. PubMed ID: 2715670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.
    Johnston MI; Preble OT; Imai J; Jacobsen H; Torrence PF
    J Immunol Methods; 1983 Dec; 65(1-2):123-35. PubMed ID: 6361140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
    Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
    Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.
    Bruchelt G; Fierlbeck G; Schiebel U; Bogenschütz O; Rassner G; Niethammer D
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):521-8. PubMed ID: 1457613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.
    Giannelli G; Antonelli G; Fera G; Dianzani F; Schiraldi O
    J Interferon Res; 1993 Feb; 13(1):57-60. PubMed ID: 8454912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon/2-5A synthetase system in primary preleukaemia patients.
    Justesen J; Hokland P; Hokland M
    Prog Clin Biol Res; 1985; 202():439-47. PubMed ID: 3868780
    [No Abstract]   [Full Text] [Related]  

  • 20. 2',5' Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
    Gastroenterol Jpn; 1991 Oct; 26(5):603-10. PubMed ID: 1752391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.